Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MD.0000000000025173 http://scihub22266oqcxt.onion/10.1097/MD.0000000000025173 33761696!9282040!33761696     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Medicine+(Baltimore) 2021 ; 100 (12): e25173 Nephropedia Template TP {{tp|p=33761696|t=2021. Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report |pdf=|usr=}}{{33761696}} gab.com Text Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report JO: Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=33761696 #FOAvip RATIONALE: Bacterial and fungal infections in Coronavirus Disease-19 (COVID-19) patients have been inadequately investigated and reported thus far. The safety profile of tocilizumab (TCZ) administration in candidemia patient still debatable. PATIENT CONCERNS: A 54 year-old woman presenting with weakness on the left side of her body was diagnosed with COVID-19. After 7 days of admission, her condition worsened and developed respiratory distress and was having respiratory distress despite standard treatment. DIAGNOSES: Acute respiratory distress syndrome (ARDS) in COVID 19 was diagnoses based on real time-PCR swab, deterioration of PaO2/FiO2 and increased of acute phase reactants. INTERVENTIONS: Anti Interleukin-6 (IL-6) was considered to tackle her inflammatory condition. Prior to TCZ administration, blood culture was performed and the result came with Candida tropicalis in the absence of bacterial growth. OUTCOMES: No major complications associated with intravenous antifungal or TCZ occurred. After 40 days of hospitalization, the patient's clinical condition improved and was finally discharged. LESSONS: This case underscores the safety profile of giving TCZ in candidemia as a secondary infection in severe COVID-19 patient. Twit Text FOAVip Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report ????Medicine (Baltimore) http://www.kidney.de/pget.php?&tw=1&pmid=33761696 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33761696 #FOAvip English Wikipedia <ref>{{Cite pmid|33761696}}</ref> Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report #MMPMID33761696 Sari AP; Darnindro N; Yohanes A; Mokoagow MI Medicine (Baltimore) 2021[Mar]; 100 (12): e25173 PMID33761696show ga RATIONALE: Bacterial and fungal infections in Coronavirus Disease-19 (COVID-19) patients have been inadequately investigated and reported thus far. The safety profile of tocilizumab (TCZ) administration in candidemia patient still debatable. PATIENT CONCERNS: A 54 year-old woman presenting with weakness on the left side of her body was diagnosed with COVID-19. After 7 days of admission, her condition worsened and developed respiratory distress and was having respiratory distress despite standard treatment. DIAGNOSES: Acute respiratory distress syndrome (ARDS) in COVID 19 was diagnoses based on real time-PCR swab, deterioration of PaO2/FiO2 and increased of acute phase reactants. INTERVENTIONS: Anti Interleukin-6 (IL-6) was considered to tackle her inflammatory condition. Prior to TCZ administration, blood culture was performed and the result came with Candida tropicalis in the absence of bacterial growth. OUTCOMES: No major complications associated with intravenous antifungal or TCZ occurred. After 40 days of hospitalization, the patient's clinical condition improved and was finally discharged. LESSONS: This case underscores the safety profile of giving TCZ in candidemia as a secondary infection in severe COVID-19 patient. |*COVID-19 Drug Treatment[MESH] |Antibodies, Monoclonal, Humanized/adverse effects/*therapeutic use[MESH] |Antifungal Agents/*therapeutic use[MESH] |COVID-19/*complications[MESH] |Candida tropicalis[MESH] |Candidemia/*complications/*drug therapy[MESH] |Coinfection[MESH] |Female[MESH] |Humans[MESH] |Interleukin-6/*antagonists & inhibitors[MESH] |Micafungin/therapeutic use[MESH] |Middle Aged[MESH]Role of tocilizumab for concomitant systemic fungal infection in sever(epmc).pdf DeepDyve Pubget Overpricing